Does Pregnancy-Associated Plasma Protein A (PAPP-A) serve as a marker for acute coronary syndromes?
PAPP-A is proposed as a novel biomarker for plaque instability and acute coronary syndromes.
PAPP-A is present in unstable plaques, and circulating levels are elevated in acute coronary syndromes; these increased levels may reflect the instability of atherosclerotic plaques. PAPP-A is a new candidate marker of unstable angina and acute myocardial infarction.
Bayés‐Genís et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: